Tue, Aug 27, 2024
Bharat Biotech International Ltd has launched Hillchol (BBV131), a novel single-strain oral cholera vaccine developed under license from Hilleman Laboratories.
More >
Tue, Nov 28, 2023
Vaccines major Bharat Biotech International Ltd on Tuesday said it has entered into a collaboration with the University of Sydney Infectious Diseases Institute to advance vaccine research initiatives, strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.
Tue, Dec 27, 2022
The price for one dose of Bharat Biotech’s intranasal vaccine iNCOVACC has been revealed. Bharat Biotech’s iNNOVACC is now available on CoWin, priced at ₹800 for private hospitals and ₹325 for a government hospitals. Know the complete details from Ambarish Pandey in this video.
Mon, Jan 04, 2021
Bharat Biotech's Covaxin is an exception as it is still in Phase-3 and yet to complete trial recruitment. No interim analysis of efficacy is available and pre-print Phase-1/2 data have only given details on immunogenicity and not efficacy of the vaccine. The emergency use approval, even as a back-up vaccine, is therefore highly unusual. Government authorities have announced that Serum's Covishield will remain the primary vaccine for the time being and Bharat Biotech's Covaxin will be in back-up, only to be used in case of a surge in case.
Mon, Dec 21, 2020
Covid-19 vaccine: Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the inactivated vaccines being developed by it for Covid 19 are safest, and hence, the adverse reactions are lesser.
Mon, Nov 16, 2020
COVID-19 vaccine - Covaxin - being developed by Bharat Biotech, is now undergoing phase-3 trials, Chairman and Managing Director of the company Krishna Ella said on Monday.
Fri, Oct 23, 2020
Bharat Biotech is in discussions with more than 10 countries that have shown an interest in a potential COVID-19 vaccine it is developing with a government agency, a company executive told Reuters on Friday.
Sun, Sep 06, 2020
The stage is set for phase II clinical trials of Bharat Biotech's coronavirus vaccine from Monday.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
